NPPA Advised Reduction in the Prices of drugs

NPPA, the Drug Pricing regulator of the Country asked Various Pharmaceutical Companies & makers of medical devices to reduce the prices of products as the Government lowered the GST for the welfare of the Consumers. NPPA (National Pharmaceutical Pricing Authority) declared the notification and said that the lowering of the GST by the Government has an impact on the Maximum Retail prices (MRP) of the Drugs & various Formulations. DPCO Notice suggest that it consists of taxes.